• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

    2/3/23 3:00:59 PM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email
    SC 13G/A 1 d458365dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 5)

     

     

    ICL Group Ltd.

    (Name of Issuer)

    Ordinary Shares, par value NIS 1.00 per share

    (Title of Class of Securities)

    M53213100

    (CUSIP Number)

    December 31, 2022

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. M53213100    ICL Group Ltd.

     

      1    

      NAME OF REPORTING PERSONS: Israel Corporation Ltd.

      I.R.S. IDENTIFICATION NOS.

      OF ABOVE PERSONS: 000000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      567,012,091 (1)

       6  

      SHARED VOTING POWER

     

      0

       7  

      SOLE DISPOSITIVE POWER

     

      567,012,091 (1)

       8  

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      567,012,091 (1)

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      43.98%(2)

    12  

      TYPE OF REPORTING PERSON (See Instructions)

     

      CO

     

    (1)

    Represents 567,012,091 ordinary shares (“Ordinary Shares”), par value NIS 1.00 per share of ICL Group Ltd. (“ICL”).

    (2)

    Based on 1,289,178,854 Ordinary Shares issued and outstanding as of December 31, 2022, which is the number of outstanding shares published by the Tel Aviv Stock Exchange, adjusted for stock option exercises.

     

    2


    Item 1.

     

      (a)

    Name of Issuer:

    ICL Group Ltd.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    Millennium Tower

    23 Aranha Street

    P.O. Box 20245

    Tel Aviv, 61202 Israel

    Item 2.

     

      (a)

    Name of Person Filing:

    Israel Corporation Ltd.

     

      (b)

    Address of Principal Business Office, or if none, Residence:

    The address of the principal business office of Israel Corp. is:

    Millennium Tower

    23 Aranha Street

    P.O. Box 20456

    Tel Aviv 61204 Israel

     

      (c)

    Citizenship:

    Israel Corp. is organized under the laws of Israel

     

      (d)

    Title of Class of Securities:

    Ordinary Shares, par value NIS 1.00 per share

     

      (e)

    CUSIP Number:

    M53213100

     

    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    Not applicable

     

    Item 4.

    Ownership.

     

      (a)

    Amount beneficially owned: 567,012,091 (1)

     

      (b)

    Percent of class: 43.98%(2)

     

      (c)

    Number of shares as to which Israel Corp. has:

    (i) Sole power to vote or to direct the vote: 567,012,091 (1)

    (ii) Shared power to vote or to direct the vote: 0

    (iii) Sole power to dispose or to direct the disposition of: 567,012,091 (1)

    (iv) Shared power to dispose or to direct the disposition of: 0

     

    (1)

    Represents 567,012,091 Ordinary Shares of ICL.

    (2)

    Based on 1,289,178,854 Ordinary Shares issued and outstanding as of December 31, 2022, which is the number of outstanding shares published by the Tel Aviv Stock Exchange, adjusted for stock option exercises.

     

    3


    Item 5.

    Ownership of Five Percent or Less of a Class.

    Not applicable

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Israel Corp. is a public company traded on the Tel Aviv Stock Exchange. As such, all decisions relating to the voting or disposition of stock of ICL are made by the board of directors of Israel Corp. or its designees. In accordance with the Israel Companies Law – 1999, at least two “external directors” (as such term is defined under the Israel Companies Law – 1999) are members of Israel Corp.’s board of directors.

    As of January 23, 2023, A discretionary trust, in which Mr. Idan Ofer is the beneficiary, indirectly holds 84.73% of the economic interest in Millenium Investments Elad Ltd. (“Millenium”), which holds approximately 44.4% of the issued and outstanding shares of Israel Corp. The foregoing discretionary trust also indirectly holds an additional approximately 0.74% of the issued and outstanding shares of Israel Corp. A second discretionary trust in which Mr. Ofer is the beneficiary controls 50% of the ordinary share capital of a company that indirectly holds 15.27% of the economic interest in Millennium. Another company controlled by the foregoing discretionary trust also holds directly approximately 1.25% of the issued and outstanding shares of Israel Corp. Mr. Ofer also directly holds approximately 3.90% of the issued and outstanding shares of Israel Corp. Each of the foregoing Israel Corp. holders disclaims beneficial ownership of any securities of ICL held by Israel Corp., except to the extent of its pecuniary interest therein, if any.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

    Not applicable

     

    Item 8.

    Identification and Classification of Members of the Group.

    Not applicable

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable

     

    Item 10.

    Certification.

    Not applicable

     

    4


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 03, 2023

     

    Israel Corporation Ltd.
    By:   /s/ Yoav Doppelt
      Name: Yoav Doppelt
      Title: Chief Executive Officer
    By:   /s/ Maya Alcheh-Kaplan
      Name: Maya Alcheh-Kaplan
      Title: Executive Vice President, General Counsel

     

    5

    Get the next $ICL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      11/14/24 6:11:02 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G filed by ICL Group Ltd.

      SC 13G - ICL Group Ltd. (0000941221) (Subject)

      1/31/24 6:05:59 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      1/30/24 8:10:40 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    SEC Filings

    See more
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/20/25 4:20:09 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 2:51:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 6:50:24 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

      1/21/25 7:50:33 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group downgraded by Barclays with a new price target

      Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

      1/12/24 6:56:19 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

      11/14/23 7:37:49 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Financials

    Live finance-specific insights

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    See more
    • ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

      12/23/24 2:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces Planned Departure of President and CEO Raviv Zoller

      Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

      12/5/24 7:21:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Recognized by Fortune as a Company That is Changing the World

      Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

      10/15/24 4:15:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials